ALTERITY THERAPEUTICS LTD (ATHE) Form 6-K — Oct 23, 2026
Alterity Therapeutics filed a Form 6-K for October 2026 as a foreign private issuer, incorporating the filing into its existing S-8 and F-3 registration statements. The filing submits a single exhibit (99.1), described only as a notification regarding unquoted securities (ASX ticker ATH), which is provided as an image with no readable text content.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.